Ani Pharmaceuticals (ANIP) Common Equity (2010 - 2026)
Ani Pharmaceuticals' Common Equity was $597.21 million in Q2 2026, up 36.7% from $436.76 million a year earlier and up 6.2% from the prior quarter.
Ani Pharmaceuticals (ANIP) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Ani Pharmaceuticals came in at $540.72 million, up 33.9% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
- In earlier years, Common Equity was $403.68 million in FY2024 (-6.7%), $432.75 million in FY2023 (+38.0%), $313.69 million in FY2022 (-6.0%) and $333.89 million in FY2021 (+70.6%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2010.
- Compared with a year earlier, Common Equity has increased for four straight quarters, with growth averaging 13.2% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 70.6%); the worst was Q1 2025 (a decline of 7.4%).
- Per Business Quant data, ANIP's Common Equity in the three quarters before Q2 2026 was $562.3 million (Q1 2026), $540.72 million (Q4 2025) and $505.82 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn | 597.21 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 597.21 Mn |
| Mar 31, 2026 | 562.30 Mn |
| Dec 31, 2025 | 540.72 Mn |
| Sep 30, 2025 | 505.82 Mn |
| Jun 30, 2025 | 436.76 Mn |
| Mar 31, 2025 | 418.62 Mn |
| Dec 31, 2024 | 403.68 Mn |
| Sep 30, 2024 | 405.95 Mn |
| Jun 30, 2024 | 455.76 Mn |
| Mar 31, 2024 | 451.96 Mn |
| Dec 31, 2023 | 432.75 Mn |
| Sep 30, 2023 | 429.86 Mn |
| Jun 30, 2023 | 409.62 Mn |
| Mar 31, 2023 | 314.63 Mn |
| Dec 31, 2022 | 313.69 Mn |
| Sep 30, 2022 | 311.83 Mn |
| Jun 30, 2022 | 312.11 Mn |
| Mar 31, 2022 | 321.24 Mn |
| Dec 31, 2021 | 333.89 Mn |
| Sep 30, 2021 | 191.40 Mn |
Ani Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();